Skip to content

ArisGlobal Blogs

Categories
Tags: ArisGlobal Blogs lifesphere clinical

From reporting challenges to data integration and data silos with clinical data management, to the continuing search for greater automation,…

Learn More
Tags: ArisGlobal Blogs e2b
Connected to the Future: Making Drug Safety Databases Transparent, E2B R3 Compliant and Cost-Effective

As different regulatory authorities have different timelines for adoption of these standards, E2B(R2) E2B(R3) will have to coexist. But having to operate two solutions creates huge complexities, unless you find a solution compliant with both. ArisGlobal LifeSphere Safety MultiVigilance is the only drug safety database solution provider thus far to provide full compliance to E2B R2 and E2B R3 standards for both import and export.

Learn More
Tags: ArisGlobal Blogs Pharmacovigilance
Blog: Automation in ICSR Processing – Is Artificial Intelligence the Paradigm Shift in Pharmacovigilance?

Artificial intelligence (AI), machine learning, deep learning, natural language processing – in short, cognitive computing, is changing the pharmacovigilance world…

Learn More
Tags: ArisGlobal Blogs lifesphere
Breaking Down Silos across the Life Sciences Enterprise Helps Drive Innovation

Silos have long plagued the life sciences industry, and nowhere is this more notable than with how information and data…

Learn More
Tags: ArisGlobal Blogs LifeSphere Medical Affairs

Today’s Medical Information (MI) and Medical Affairs professionals are juggling multiple challenges: they must adapt to decentralization, outsourcing and globalization…

Learn More
Tags: ArisGlobal Blogs LifeSphere Safety

Safety departments at Marketing Authorization Holders & Regulatory Authorities are under pressure from all sides. They must constantly stay on…

Learn More
Tags: ArisGlobal Blogs regulatory affairs regulatory information management

Rising Expectations from Regulatory Affairs Executives As we all know from experience, not all cloud solutions are the same and…

Learn More
Tags: ArisGlobal Blogs Pharmacovigilance

Artificial intelligence (AI), machine learning, deep learning, natural language processing – in short, cognitive computing, is changing the pharmacovigilance world as we know it. While there’s a lot of talk about how AI will affect jobs, where it will have the most powerful impact is on the quality of work and the speed at which manual tasks can be accomplished.

Learn More
Tags: ArisGlobal Blogs regulatory affairs

This is the last in the ArisGlobal three-part blog series on Regulatory Affairs transformation. Digitization is sweeping the life sciences industry, disrupting traditional working practices and opening doors to better ways of collaborating, tracking and sharing documents and data, and gaining clear oversight into the product supply chain.

Learn More
Tags: ArisGlobal Blogs regulatory affairs

The life sciences industry is confronting a wave of transformational change, brought about by multiple factors, including the growth of new clinical trial markets, a rapid rise in drug development innovation, reimbursement challenges, heightened regulatory requirements and a demand for evidence-based medicine, among many others. These drivers and the resultant changes are having a profound effect on regulatory affairs.

Learn More
ArisGlobal Launches LifeSphere NavaX™   Learn More

Join us at Breakthrough 2024 to explore life sciences transformation through Intelligent Automation

Registration is closed!